Allergan announced the launch of the over-the-counter (OTC) artificial tear REFRESH OPTIVE MEGA-3, the latest innovation in the REFRESH portfolio that fortifies the lipid layer when Meibomian Gland Dysfunction (MGD) patients suffer from Dry Eye. MEGA-3 is formulated with flaxseed and castor oil, two natural, plant-based oils which protect tears from evaporating while nourishing the lipid layer damaged by Dry Eye and providing essential hydration to all three layers of the tear film. It’s clinically proven to treat the signs and symptoms of Dry Eye.
“I recommend MEGA-3 for patients suffering from Dry Eye symptoms associated with MGD, who are looking for relief. In addition, MEGA-3 is specially formulated for stability, so no shaking is required — just drop and go.” said Milton M. Hom, OD, FAAO.
An estimated 25 million people in the United States suffer from Dry Eye symptoms, including irritation, blurred vision, sensitivity to light, burning, stinging, dryness and excessive tearing. MEGA-3 also contains carboxymethylcellulose (CMC), an active lubricant found in all REFRESH OPTIVE formulas. This water-loving polymer, binds to epithelial cells to maintain moisture on the ocular surface for rapid on-eye comfort and long-lasting relief.
“As the innovators of the number one doctor-recommended brand of artificial tears, we are pleased to expand our robust dry eye portfolio with REFRESH OPTIVE MEGA-3,” said Herm Cukier, Senior Vice President, Eye Care. “Our REFRESH line of patented products offer patients a wide variety of options to treat their individual dry eye needs.”
All OPTIVE products include the patented osmoprotectant formula that includes three compatible solutes — glycerin, I-carnitine and erythritol — all of which deliver added protection to the corneal epithelial cells against hypertonic stress. REFRESH OPTIVE MEGA-3 contains a fourth osmoprotectant, trehalose, for an advanced approach to treating Dry Eye symptoms.
MEGA-3 is available in 30-count single-use vials and can be found nationwide at various retail locations where OTC eye drops are sold.
Source: Allergan